The chemiluminescence-based immunoassay is used for the direct quantitative measurement of free testosterone in serum or plasma, with results in 48 minutes.

Biomy has developed its DeepPathFinder digital pathology platform to analyze images to classify cell and tissue types in specific regions.

The NCI-led Vanguard study has selected tests from Guardant Health and ClearNote Health to move forward after a vigorous technology assessment. The company recently published data demonstrating its ...

Innovaccer on Thursday announced separately that it has closed a $275 million Series F funding round that includes participation from Danaher Ventures and others.

Rounding out the other four largest financing rounds in 2024 are proteomics company Alamar Biosciences' $128 million Series C ...

Labcorp will take over the daily operations of three Inspira Health hospital labs, and it will serve as the primary lab for Inspira's physician network.

The expanded clearance adds the Ventana DP 600 slide scanner to Roche's previous whole-slide imaging system that was cleared last year.

Anbio Biotechnology has launched its Dry Chemiluminescence Immunoassay Solution ADL-1000. The platform was developed to deliver rapid, reliable, and cost-effective diagnostic results, the ...